
Cell Based Assays - Sartorius
The development of protein-based therapeutics requires comprehensive product analysis. Complete characterization calls for the use of distinct and complementary methods, including structural and …
Recent Advances on Cell Culture Platforms for In Vitro Drug Screening ...
The clinical translations of drugs and nanomedicines depend on coherent pharmaceutical research based on biologically accurate screening approaches. Since establishing the 2D in vitro cell culture …
Recent Advances on Cell Culture Platforms for In Vitro Drug Screening ...
Mar 10, 2023 · The clinical translations of drugs and nanomedicines depend on coherent pharmaceutical research based on biologically accurate screening approaches. Since establishing the 2D in vitro cell …
Engineering the next generation of cell-based therapeutics
May 30, 2022 · Cell-based therapeutics are an emerging modality with the potential to treat many currently intractable diseases through uniquely powerful modes of action. Despite notable recent …
iPSC Cell Therapy Platform Overview | Evotec
This involves all steps from research to development up to clinical testing of cell therapy product candidates in patients. Thus, it comprises an end-to-end integrated process flow from project …
Cell-Based vs. Non-Cell-Based NAb Assays: Which Method is Right for ...
Oct 29, 2024 · The choice between non-cell-based and cell-based NAb assays for routine immunogenicity testing is a topic of frequent debate in industry forums. This is especially true if the …
3D Cell Culture Platforms as Drug Development Tools
Aug 23, 2021 · CDER researchers are investigating cell culture platforms that can supplant the need for animal testing or clinical trials in specific regulatory contexts.
Three-Dimensional Culture System: A New Frontier in Cancer Research ...
Jul 16, 2025 · The pursuit of novel therapies has encouraged the development of novel model approaches in cancer research, drug discovery processes, and stem cell therapies. In the last …
Stem cells, organoids, and organ-on-a-chip models for personalized
Dec 1, 2021 · For this purpose, patient- and disease-specific drug testing platforms based on recent developments in stem cell, organoid, and organ-on-a-chip (OoC) technologies would provide a very …
Multi-lineage Human iPSC-Derived Platforms for Disease ... - Cell Press
Sharma et al. review recent advances in multi-cell-lineage, hiPSC-derived platforms for disease modeling and drug screening. These complex model systems, which include organoids, …